HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick A Singleton Selected Research

Prostatic Neoplasms (Prostate Cancer)

3/2011The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
8/2010Effect of perioperative opioids on cancer recurrence: a hypothesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick A Singleton Research Topics

Disease

17Neoplasms (Cancer)
08/2015 - 10/2002
7Lung Neoplasms (Lung Cancer)
01/2015 - 09/2009
7Acute Lung Injury
07/2014 - 04/2009
7Lung Injury
03/2012 - 10/2007
4Neoplasm Metastasis (Metastasis)
01/2015 - 03/2011
4Breast Neoplasms (Breast Cancer)
08/2010 - 10/2002
3Ventilator-Induced Lung Injury
07/2014 - 04/2009
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 06/2010
3Sepsis (Septicemia)
08/2011 - 04/2005
3Pneumonia (Pneumonitis)
01/2011 - 12/2009
2Hyperoxia
03/2012 - 12/2009
2Pulmonary Hypertension
08/2011 - 04/2008
2Prostatic Neoplasms (Prostate Cancer)
03/2011 - 08/2010
1COVID-19
04/2023
1Opioid-Induced Constipation
08/2015
1Chronic Pain
08/2015
1Adenocarcinoma of Lung
01/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2013
1Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
04/2012
1Lung Diseases (Lung Disease)
08/2011
1Chronic Obstructive Pulmonary Disease (COPD)
08/2011
1Asthma (Bronchial Asthma)
08/2011
1Lewis Lung Carcinoma
03/2011
1Vascular Diseases (Vascular Disease)
01/2011
1Respiratory Insufficiency (Respiratory Failure)
01/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2010
1Reperfusion Injury
12/2009

Drug/Important Bio-Agent (IBA)

9Hyaluronic Acid (Hyaluronan)IBA
01/2015 - 10/2002
5methylnaltrexoneFDA Link
08/2015 - 06/2008
5Opioid Analgesics (Opioids)IBA
08/2015 - 08/2010
5Proteins (Proteins, Gene)FDA Link
07/2013 - 10/2002
4mu Opioid Receptors (mu Opioid Receptor)IBA
08/2015 - 06/2008
4Small Interfering RNA (siRNA)IBA
01/2015 - 12/2009
4Anesthetics (Anesthetic Agents)IBA
01/2014 - 08/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 12/2009
4Opioid Receptors (Opioid Receptor)IBA
04/2012 - 08/2010
4LipopolysaccharidesIBA
08/2011 - 10/2007
3Carrier Proteins (Binding Protein)IBA
01/2014 - 01/2011
3Caveolin 1IBA
11/2010 - 04/2009
2Narcotic Antagonists (Opioid Antagonists)IBA
08/2015 - 03/2011
2NestinIBA
01/2015 - 04/2012
2Serine Proteases (Serine Protease)IBA
01/2015 - 04/2005
2GlycosaminoglycansIBA
01/2015 - 08/2011
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2014 - 12/2009
2oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA
07/2014 - 04/2009
2Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2014 - 08/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 04/2008
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2012 - 10/2010
2NADPH Oxidases (NAD(P)H oxidase)IBA
03/2012 - 12/2009
2Myosin-Light-Chain KinaseIBA
03/2012 - 01/2011
2Tyrosine (L-Tyrosine)FDA Link
03/2012 - 12/2009
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
03/2012 - 12/2009
2Opiate AlkaloidsIBA
03/2011 - 08/2010
2Phosphotransferases (Kinase)IBA
01/2011 - 10/2002
2RNA (Ribonucleic Acid)IBA
01/2011 - 04/2008
2DNA (Deoxyribonucleic Acid)IBA
06/2010 - 09/2009
2TOR Serine-Threonine KinasesIBA
06/2010 - 02/2010
2CytokinesIBA
05/2009 - 08/2003
2rho-Associated KinasesIBA
06/2004 - 08/2003
1SaltsIBA
04/2023
1Hyaluronan ReceptorsIBA
01/2015
1Plasminogen Activators (Plasminogen Activator)IBA
01/2015
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2015
1EphrinsIBA
08/2014
1Interleukin-6 (Interleukin 6)IBA
07/2014
1Growth Factor ReceptorsIBA
01/2014
1Apoptosis Regulatory ProteinsIBA
07/2013
1PaxillinIBA
07/2013
1Cisplatin (Platino)FDA LinkGeneric
07/2013
1Biomarkers (Surrogate Marker)IBA
11/2012
1Blood Proteins (Serum Proteins)IBA
11/2012
1temsirolimusFDA Link
04/2012
1CortactinIBA
03/2012
1Cytoskeletal ProteinsIBA
03/2012
1Superoxides (Superoxide)IBA
03/2012
1EnzymesIBA
08/2011
1AgarIBA
03/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2011
1Peptides (Polypeptides)IBA
01/2011
1Protein Isoforms (Isoforms)IBA
01/2011
1Liposomes (Liposome)IBA
01/2011
1Sphingosine-1-Phosphate ReceptorsIBA
10/2010
1SEW2871IBA
10/2010
1SphingolipidsIBA
10/2010
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2010
1Therapeutic UsesIBA
10/2010
1Morphine (MS Contin)FDA LinkGeneric
08/2010
1General AnestheticsIBA
08/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2010
1MTOR InhibitorsIBA
02/2010
1GTP Phosphohydrolases (GTPases)IBA
12/2009
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
12/2009

Therapy/Procedure

4Mechanical Ventilators (Ventilator)
01/2011 - 05/2009
3Therapeutics
08/2015 - 02/2010
2Analgesia
08/2015 - 08/2010
2Ligation
10/2010 - 04/2005
1Perioperative Period
08/2015
1Intravenous Injections
01/2011
1Artificial Respiration (Mechanical Ventilation)
01/2011
1Intravenous Administration
10/2010